Medical Accuracy First
Every piece is created or reviewed by a licensed clinician or credentialed life-science expert. Named, not anonymous.
A peer-reviewed content studio for healthcare brands. 14 years of publishing rigor, 14,000+ clinician-bylined articles, and 28+ client engagements since 2023 across clinics, treatment centers, digital health brands, and specialty publishers. The playbook was proven on our own properties. It now compounds for yours.
Multi-location medical practices, specialty groups, dental & concierge.
DTC supplement, OTC, device, wearable & app brands.
Consumer health publishers, comparison sites & review media.
Addiction, behavioral health, IOP/PHP & residential programs.
Chris Riley has been building peer-reviewed health content since 2012. It started at USARx.com, where his team grew the site from zero to 1.5M organic sessions / mo by 2023. He went on to build a second editorial portfolio (Diabetic.org, Pharmacists.org, Allergies.org) that was exited in 2023. Experts Ink is that playbook productized, now running for US clinics, brands, publishers, and treatment centers.
Search engines got smarter. Consumers got skeptical. LLMs made generic health content infinitely cheap. The only defensible content left is content written (and reviewed) by named, credentialed experts.
That's all Experts Ink does. We match your brief to a licensed clinician or PhD, ship a sourced draft, put it through a second expert review, and hand it back byline-ready.
How we operateEvery piece is created or reviewed by a licensed clinician or credentialed life-science expert. Named, not anonymous.
Two-expert review on YMYL pieces. Primary-source citations, version history, and a paper trail a regulator would respect.
Search performance and clinical accuracy aren't a trade-off. Our workflow ships 40+ reviewed pieces a month without cutting either.
Every line on every chart below is real Google Analytics. USARx.com is the 11-year flagship Chris led (2012-2023). Diabetic.org, Pharmacists.org, and Allergies.org were a separate owned portfolio Chris built and exited in 2023. Circufiber.com was a 2+ year Experts Ink client engagement in the DTC diabetic-sock category. Beyond what's shown, Experts Ink runs 28+ current client engagements across treatment centers, behavioral health, specialty pharmacy, DTC brands, telehealth, and consumer health publishing. Almost all are under NDA at client request and referenced in aggregate below.
14,000 peer-reviewed articles over 11 years. The site that became the playbook for Experts Ink.
A DTC diabetic-sock brand Experts Ink built the podiatrist-reviewed content layer for over 2+ years.
A CDCES-reviewed diabetes publisher that went head-to-head with Healthline on hundreds of high-intent queries.
Built into the highest-ranking independent PharmD authority site on the open web, then acquired.
SEO-ranked, expert-written, clinically reviewed long-form content.
Topical clusters, keyword maps, and an editorial calendar aligned to revenue.
Health literacy materials patients actually read.
Credentialed names, on your brand page, with legal and editorial cover.
Instant credibility in our space. Within weeks we saw a noticeable increase in organic traffic and qualified inquiries.
A trusted partner for long-term growth. It wasn't just SEO. It was trust at scale, built around our mission of patient care.
A massive boost in conversions after working with Experts Ink. The ROI was immediate and undeniable.
Every deliverable ships through the same editorial pipeline. No shortcuts, no anonymous bylines.
We map your audience, search intent, regulatory posture, and in-house SME availability before a word is written.
A credentialed clinician or scientist is matched by specialty, license state, and voice fit, within 48 hours.
Writer drafts against primary sources (PubMed, ClinicalKey, guideline bodies). No secondary-source recycling.
An independent second expert reviews for clinical accuracy, balance, and completeness.
Our managing editor handles voice, structure, on-page SEO, internal linking, and Schema.org markup.
You receive a byline, a disclosure, a review note, and a source log. Archived on our end for audit.
Treatment-center SEO is a YMYL minefield. The E-E-A-T signals, compliance stack, and editorial guardrails that move rankings without triggering LegitScript or Google's Helpful Content classifier.
HIPAA, YMYL, and the modern E-E-A-T stack. What actually moves the needle for medical practices, multi-location clinics, and specialty groups in 2026.
GBP optimization, citation strategy, review velocity, city-page structure, and the NAP mistakes we see on 80% of multi-location practice audits.
Short, direct answers to the ones that come up on every discovery call. Nothing else is worth the airtime.
A credentialed expert matched to your topic (a licensed MD, DO, PharmD, PhD, RD, NP, or PsyD) drafts the piece from primary sources. A second, independent expert reviews it for clinical accuracy before our managing editor handles voice and structure. Every deliverable ships with a named byline, a disclosure, and a sourcing log.
Three things: (1) our reviewers are real, verifiable people with linked-out professional profiles, not rented badges; (2) every YMYL piece gets an independent second-expert peer review, not just a single pass; (3) we archive the full paper trail so a regulator, journalist, or your legal team can audit any piece we've published.
We use AI for research acceleration, outlining, and editorial QA. Never as the author. Every published word is written and reviewed by a credentialed human. We'll tell you exactly how AI is used in your workflow and show you the audit trail.
Every engagement is scoped individually. No two clients on our book look the same, and pricing tracks the actual work: research depth, licensure of the reviewing clinician, SME time, volume, and regulatory weight. Not word count. Most clients start with a short paid pilot so both sides can pressure-test fit before committing. From there we prefer a 3-month minimum on any ongoing editorial partnership, which gives the process room to prove itself in a way a single article can't. Send us a brief and we will come back with a real number tied to your actual scope.
Median expert match within 48 hours. Median first draft delivered in 8 business days. Median fully reviewed, editor-polished delivery within 10 business days. Rush engagements are available on retainers.
Yes. That's usually the point. Every engagement includes a disclosure letter and a linked-out clinician profile you can surface on the page. We handle the conflict-of-interest attestation and the ongoing review cadence if the content ever needs updating.
Yes. Primarily Canada, UK, and Australia. We match jurisdiction-appropriate experts (e.g. a UK-registered GMC clinician for UK brands) and adapt content to local regulatory context (MHRA, TGA, Health Canada).
Yes. We run white-label editorial desks for a handful of agencies and in-house teams. Same process, delivered under your brand, with our reviewers as named clinical consultants if you'd like that surfaced.
A topic, a keyword, or a full outline, whatever you have. Within three business days we'll come back with a sample outline for the piece, a quick audit of your existing content, related recommendations, and a scoped pilot quote. The pilot is the sample article itself.